CC
Chardan Capital Latest Price Targets & Analyst Ratings
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
26 |
26
Regenxbio
RGNX
$490M
|
DG
Daniil Gataulin
| $9.71 | $52 |
436%
upside
| Buy | 1 month ago |
|
27 |
SLN
27
Silence Therapeutics
SLN
$269M
|
KN
Keay Nakae
| $5.69 | $35 |
515%
upside
| Buy | 1 month ago |
|
28 |
28
EyePoint Pharmaceuticals
EYPT
$966M
|
DG
Daniil Gataulin
| $14.01 | $27 |
93%
upside
| Buy | 1 month ago |
|
29 |
29
CRISPR Therapeutics
CRSP
$4.99B
|
GL
Geulah Livshits
| $54.86 | $82 |
49%
upside
| Buy | 1 month ago |
|
30 |
30
Ocugen
OCGN
$322M
|
DG
Daniil Gataulin
| $1.03 | $7 |
580%
upside
| Buy | 1 month ago |
|
31 |
31
MindMed
MNMD
$702M
|
RL
Rudy Li
| $9.22 | $20 |
117%
upside
| Buy | 1 month ago |
|
32 |
32
Alnylam Pharmaceuticals
ALNY
$59.2B
|
KN
Keay Nakae
| $452 | $400 |
12%
downside
| Buy | 1 month ago |
|
33 |
33
Praxis Precision Medicines
PRAX
$986M
|
RL
Rudy Li
| $46.85 | $80 |
71%
upside
| Buy | 1 month ago |
|
34 |
34
Dyne Therapeutics
DYN
$2.02B
|
KN
Keay Nakae
| $14.22 | $38 |
167%
upside
| Buy | 1 month ago |
|
35 |
DRUG
35
Bright Minds Biosciences
DRUG
$299M
|
RL
Rudy Li
| $42.24 | $80 |
89%
upside
| Buy | 3 months ago |
|
36 |
36
Oculis Holding
OCS
$901M
|
DG
Daniil Gataulin
| $17.22 | $33 |
92%
upside
| Buy | 4 months ago |
|
37 |
37
Innodata
INOD
$1.38B
|
HK
Hamed Khorsand
| $43.48 | $45 |
4%
upside
| Buy | 8 months ago |
|
38 |
38
VinFast Auto
VFS
$7.81B
|
BD
Brian Dobson
| $3.34 | $13 |
289%
upside
| Buy | 1 year ago |
|
39 |
39
CleanSpark
CLSK
$2.6B
|
BD
Brian Dobson
| $9.24 | $26 |
181%
upside
| Buy | 1 year ago |
|
40 |
40
Marathon Digital Holdings
MARA
$5.63B
|
BD
Brian Dobson
| $15.19 | $21 |
38%
upside
| Neutral | 1 year ago |
|
41 |
41
Solid Power
SLDP
$760M
|
BD
Brian Dobson
| $4.19 | $5 |
19%
upside
| Buy | 1 year ago |
|
42 |
42
Energy Vault
NRGV
$335M
|
BD
Brian Dobson
| $2.07 | $0.7500 |
64%
downside
| Sell | 1 year ago |
|
43 |
43
Ouster
OUST
$1.59B
|
BD
Brian Dobson
| $27.47 | $10 |
64%
downside
| Neutral | 1 year ago |
|
44 |
44
MeiraGTx Holdings
MGTX
$619M
|
GL
Geulah Livshits
| $7.69 | $41 |
433%
upside
| Buy | 2 years ago |
|
45 |
MESO
45
Mesoblast
MESO
$1.84B
|
KN
Keay Nakae
| $14.39 | $6 |
58%
downside
| Sell | 2 years ago |
|
46 |
46
uniQure
QURE
$985M
|
MB
Matthew Barcus
| $17.95 | $27 |
50%
upside
| Buy | 2 years ago |
|
47 |
47
Immunovant
IMVT
$2.99B
|
MB
Matthew Barcus
| $17.14 | $32 |
87%
upside
| Buy | 2 years ago |
|
48 |
48
Immatics
IMTX
$761M
|
GL
Geulah Livshits
| $6.26 | $25 |
299%
upside
| Buy | 2 years ago |
|
49 |
49
Immunome
IMNM
$916M
|
MB
Matthew Barcus
| $10.52 | $8 |
24%
downside
| Buy | 2 years ago |
|
50 |
50
Moderna
MRNA
$9.78B
|
GL
Geulah Livshits
| $25.14 | $208 |
727%
upside
| Neutral | 2 years ago |
|